BCAX EV/EBITDA
-1.71
-0.34-24.82%
Thu, 23 Jan 2025 11:15:51 GMT
Summary:
As of January 23, 2025, BCAX EV/EBITDA is -1.71, with a fall of -0.34 (-24.82%) during the most recent trading day. BCAX EV/EBITDA is now -159.09% below its all-time high of -0.66.BCAX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCAX EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | -24.8% |
| 1 m1 month | +89.7% |
| 3 m3 months | +93.2% |
| 6 m6 months | - |
| ytdytd | +87.5% |
| 1 y1 year | - |
| 5 y5 years | - |
BCAX EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -0.66 | -159.1% | -17.45 | +90.2% |
| 3 m | 3-month | -0.66 | -159.1% | -31.00 | +94.5% |
| 6 m | 6-month | -0.66 | -159.1% | -31.63 | +94.6% |
| 1 y | 1-year | -0.66 | -159.1% | -31.63 | +94.6% |
| 3 y | 3-year | -0.66 | -159.1% | -31.63 | +94.6% |
| 5 y | 5-year | -0.66 | -159.1% | -31.63 | +94.6% |
| alltime | all time | -0.66 | -159.1% | -31.63 | +94.6% |
Bicara Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -1.71(-87.5%) |
| Date | Value |
|---|---|
| 2024 | -13.65 |
FAQ
- What is Bicara Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Bicara Therapeutics?
- What is BCAX EV/EBITDA year-to-date change?
What is Bicara Therapeutics EV/EBITDA?
The current EV/EBITDA of BCAX is -1.71
What is the all time high EV/EBITDA for Bicara Therapeutics?
Bicara Therapeutics all-time high EV/EBITDA is -0.66
What is BCAX EV/EBITDA year-to-date change?
Bicara Therapeutics EV/EBITDA has changed by +11.94 (+87.47%) since the beginning of the year